Clinical Trial Update: To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing low-dose glucocorticoids versus tofacitinib for 24 weeks in moderate to high disease activity rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)
• low-dose glucocorticoids

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN